anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Compass Therapeutics | Investor Presentation Deck | 40 slides · page 39 of 40

Compass Therapeutics | Investor Presentation Deck | 40 slides · slide 39

Pitch deck · executive_summary · summarize · dense density

Deck inventory Unlock
More
Slide JSON Deck JSON
Slide locked Sign in to view
Slide schematic 4/4
list 3/3 title 1/1
Components 4
bullet bullet bullet headline
Tools 1
Executive summary slide · 90%

list/bullet: CTX-471 Potential best-in-class CD137 agonist antibody with monotherapy activity. Phase 1 monotherapy study fully enrolled. 4 partial responses (PRs) in post PD-1 population.
Metrics 0
∅
No metrics

No metric insight is anchored to this slide.

Frameworks 0
∅
No frameworks

No framework match is anchored to this slide.